Menarini Stemline · 2 weeks ago
Associate Director, US HCP Marketing, Elacestrant
Menarini Stemline is focused on transforming oncology brand engagement, and they are seeking an Associate Director for US HCP Marketing to develop and execute a peer-to-peer engagement strategy for elacestrant in metastatic breast cancer. This role involves collaboration with cross-functional partners and leading initiatives that educate and empower medical oncologists and digital opinion leaders.
BiotechnologyHealth CareHealth DiagnosticsOncology
Responsibilities
Develop and lead the Peer-to-Peer (P2P) marketing strategy for elacestrant, driving engagement among medical oncologists, thought leaders, and digital opinion leaders (DOLs)
Identify, engage, and partner with key breast cancer experts to foster scientific exchange and enhance brand advocacy
Plan and execute advisory boards, expert panels, and peer learning forums that capture actionable insights and strengthen Orserdu’s positioning
Collaborate with Medical Affairs and Commercial teams to develop speaker training programs and ensure compliant execution of P2P initiatives
Oversee creation and dissemination of speaker decks, symposium content, and congress booth experiences, ensuring alignment with brand strategy
Lead booth and additional sponsorship and advertising content including peer interaction strategies at major oncology congresses (e.g., ASCO, SABCS, ESMO)
Partner with agency and internal creative teams to develop scientific speaker decks, modular presentations, and visual assets optimized for HCP audiences
Leverage AI tools to scale video and digital content (e.g., expert interviews, panel highlights, congress recaps) for use across social media, websites, and HCP education platforms
Collaborate with Digital and Analytics teams to measure reach, engagement, and impact of P2P and DOL-driven campaigns
Drive cross-channel amplification of peer-led content to expand awareness and understanding of elacestrant’s clinical value
Partner with brand and field teams to ensure integration of P2P activities within the broader omnichannel brand strategy
Develop an annual P2P marketing plan, including budget allocation, resourcing, KPIs, and performance tracking
Lead vendor and agency management, ensuring timely and high-quality delivery of educational content and peer engagement programs
Collaborate with compliance, regulatory, and legal functions to ensure all materials and engagements meet industry standards
Establish and track P2P and DOL engagement metrics, analyzing effectiveness and identifying opportunities for improvement
Utilize insights from advisory boards, expert feedback, and digital analytics to inform ongoing strategy refinement
Identify emerging thought leaders and trends in oncology to maintain a dynamic, relevant P2P ecosystem
Qualification
Required
Bachelor's degree required; MBA, MPH, or advanced science degree preferred
Minimum 6 years of pharmaceutical marketing experience, with at least 2 years in peer-to-peer, medical education, or HCP engagement roles
Demonstrated ability to be agile and adaptable in a fast-paced commercial environment
Strong understanding of breast cancer landscape, medical oncologist community, and digital engagement trends
Proven ability to work effectively with Medical Affairs, Compliance, Regulatory, and Legal teams
Demonstrated experience leveraging AI and digital tools for content creation, personalization, or amplification
Exceptional project management, communication, and stakeholder relationship skills
Willingness to travel (approximately 15%) for congresses, meetings, and field events
Preferred
Experience leading advisory boards, speaker programs, or congress activations in oncology or specialty markets
Benefits
Short- and Long-Term Incentive Programs
Fidelity 401(k) (with company match)
Anthem Premier PPO and HDHP insurance plans
Company paid Basic Life & AD&D insurance
Pre-tax FSA/HSA programs
Company
Menarini Stemline
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$195.09MKey Investors
Pequot Capital
2020-05-04Acquired
2019-08-01Post Ipo Equity· $88M
2019-01-15Post Ipo Equity· $92M
Leadership Team
Recent News
2025-10-13
2025-09-27
Company data provided by crunchbase